nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Congestive cardiomyopathy—Riluzole—amyotrophic lateral sclerosis	0.0827	0.107	CcSEcCtD
Azacitidine—DNMT3A—peripheral nervous system—amyotrophic lateral sclerosis	0.0717	0.347	CbGeAlD
Azacitidine—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.0312	0.0406	CcSEcCtD
Azacitidine—Cardiac murmur—Riluzole—amyotrophic lateral sclerosis	0.028	0.0363	CcSEcCtD
Azacitidine—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.028	0.0363	CcSEcCtD
Azacitidine—DNMT3A—embryo—amyotrophic lateral sclerosis	0.0262	0.127	CbGeAlD
Azacitidine—Adenosine triphosphate—ASNA1—amyotrophic lateral sclerosis	0.0177	0.758	CrCbGaD
Azacitidine—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0226	CcSEcCtD
Azacitidine—DNMT1—embryo—amyotrophic lateral sclerosis	0.0158	0.0765	CbGeAlD
Azacitidine—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0203	CcSEcCtD
Azacitidine—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0199	CcSEcCtD
Azacitidine—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0196	CcSEcCtD
Azacitidine—Polyp—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0185	CcSEcCtD
Azacitidine—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0177	CcSEcCtD
Azacitidine—Cyst—Riluzole—amyotrophic lateral sclerosis	0.013	0.0169	CcSEcCtD
Azacitidine—DNMT3A—nervous system—amyotrophic lateral sclerosis	0.0126	0.0608	CbGeAlD
Azacitidine—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0159	CcSEcCtD
Azacitidine—DNMT3A—central nervous system—amyotrophic lateral sclerosis	0.0121	0.0585	CbGeAlD
Azacitidine—DNMT3A—cerebellum—amyotrophic lateral sclerosis	0.0118	0.0572	CbGeAlD
Azacitidine—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0152	CcSEcCtD
Azacitidine—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0147	CcSEcCtD
Azacitidine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0137	CcSEcCtD
Azacitidine—DNMT1—medulla oblongata—amyotrophic lateral sclerosis	0.0101	0.0489	CbGeAlD
Azacitidine—DNMT3A—brain—amyotrophic lateral sclerosis	0.0096	0.0464	CbGeAlD
Azacitidine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00954	0.0124	CcSEcCtD
Azacitidine—DNMT1—spinal cord—amyotrophic lateral sclerosis	0.00902	0.0436	CbGeAlD
Azacitidine—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00878	0.0114	CcSEcCtD
Azacitidine—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00862	0.0112	CcSEcCtD
Azacitidine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00847	0.011	CcSEcCtD
Azacitidine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00793	0.0103	CcSEcCtD
Azacitidine—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00784	0.0102	CcSEcCtD
Azacitidine—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00784	0.0102	CcSEcCtD
Azacitidine—DNMT1—nervous system—amyotrophic lateral sclerosis	0.0076	0.0368	CbGeAlD
Azacitidine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00753	0.00978	CcSEcCtD
Azacitidine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00738	0.00959	CcSEcCtD
Azacitidine—DNMT1—central nervous system—amyotrophic lateral sclerosis	0.00732	0.0354	CbGeAlD
Azacitidine—DNMT1—cerebellum—amyotrophic lateral sclerosis	0.00715	0.0346	CbGeAlD
Azacitidine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00704	0.00914	CcSEcCtD
Azacitidine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00694	0.00902	CcSEcCtD
Azacitidine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00664	0.00863	CcSEcCtD
Azacitidine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00653	0.00849	CcSEcCtD
Azacitidine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00645	0.00838	CcSEcCtD
Azacitidine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0063	0.00818	CcSEcCtD
Azacitidine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00761	CcSEcCtD
Azacitidine—DNMT1—brain—amyotrophic lateral sclerosis	0.00581	0.0281	CbGeAlD
Azacitidine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00575	0.00747	CcSEcCtD
Azacitidine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00573	0.00744	CcSEcCtD
Azacitidine—Glucosamine—MMP9—amyotrophic lateral sclerosis	0.00565	0.242	CrCbGaD
Azacitidine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00555	0.00721	CcSEcCtD
Azacitidine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00712	CcSEcCtD
Azacitidine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00544	0.00707	CcSEcCtD
Azacitidine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00523	0.0068	CcSEcCtD
Azacitidine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00517	0.00671	CcSEcCtD
Azacitidine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00661	CcSEcCtD
Azacitidine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00661	CcSEcCtD
Azacitidine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00639	CcSEcCtD
Azacitidine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00634	CcSEcCtD
Azacitidine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00485	0.0063	CcSEcCtD
Azacitidine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00485	0.0063	CcSEcCtD
Azacitidine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00628	CcSEcCtD
Azacitidine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00614	CcSEcCtD
Azacitidine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00613	CcSEcCtD
Azacitidine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00601	CcSEcCtD
Azacitidine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00596	CcSEcCtD
Azacitidine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00458	0.00594	CcSEcCtD
Azacitidine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00591	CcSEcCtD
Azacitidine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00453	0.00588	CcSEcCtD
Azacitidine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00569	CcSEcCtD
Azacitidine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00567	CcSEcCtD
Azacitidine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00566	CcSEcCtD
Azacitidine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00563	CcSEcCtD
Azacitidine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00562	CcSEcCtD
Azacitidine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0043	0.00559	CcSEcCtD
Azacitidine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00557	CcSEcCtD
Azacitidine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00556	CcSEcCtD
Azacitidine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00555	CcSEcCtD
Azacitidine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00529	CcSEcCtD
Azacitidine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00525	CcSEcCtD
Azacitidine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00513	CcSEcCtD
Azacitidine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00511	CcSEcCtD
Azacitidine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00393	0.0051	CcSEcCtD
Azacitidine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00508	CcSEcCtD
Azacitidine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00385	0.005	CcSEcCtD
Azacitidine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00496	CcSEcCtD
Azacitidine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00493	CcSEcCtD
Azacitidine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00476	CcSEcCtD
Azacitidine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00474	CcSEcCtD
Azacitidine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00457	CcSEcCtD
Azacitidine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00455	CcSEcCtD
Azacitidine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00444	CcSEcCtD
Azacitidine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00442	CcSEcCtD
Azacitidine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00441	CcSEcCtD
Azacitidine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00433	CcSEcCtD
Azacitidine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00331	0.0043	CcSEcCtD
Azacitidine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00427	CcSEcCtD
Azacitidine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00425	CcSEcCtD
Azacitidine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00419	CcSEcCtD
Azacitidine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00419	CcSEcCtD
Azacitidine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00419	CcSEcCtD
Azacitidine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00418	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00416	CcSEcCtD
Azacitidine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00414	CcSEcCtD
Azacitidine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00405	CcSEcCtD
Azacitidine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00402	CcSEcCtD
Azacitidine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00402	CcSEcCtD
Azacitidine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00399	CcSEcCtD
Azacitidine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00395	CcSEcCtD
Azacitidine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00394	CcSEcCtD
Azacitidine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00394	CcSEcCtD
Azacitidine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00392	CcSEcCtD
Azacitidine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0039	CcSEcCtD
Azacitidine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00389	CcSEcCtD
Azacitidine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00383	CcSEcCtD
Azacitidine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00376	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00366	CcSEcCtD
Azacitidine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00364	CcSEcCtD
Azacitidine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00358	CcSEcCtD
Azacitidine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00354	CcSEcCtD
Azacitidine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00349	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00347	CcSEcCtD
Azacitidine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00347	CcSEcCtD
Azacitidine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00344	CcSEcCtD
Azacitidine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00344	CcSEcCtD
Azacitidine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00331	CcSEcCtD
Azacitidine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00329	CcSEcCtD
Azacitidine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00319	CcSEcCtD
Azacitidine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00318	CcSEcCtD
Azacitidine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00318	CcSEcCtD
Azacitidine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00296	CcSEcCtD
Azacitidine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00288	CcSEcCtD
Azacitidine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00284	CcSEcCtD
Azacitidine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00275	CcSEcCtD
Azacitidine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00266	CcSEcCtD
Azacitidine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00256	CcSEcCtD
Azacitidine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00253	CcSEcCtD
Azacitidine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00253	CcSEcCtD
Azacitidine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00252	CcSEcCtD
Azacitidine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00239	CcSEcCtD
